Diffusion Tensor Imaging in the Assessment of Normal-Appearing Brain Tissue Damage in Relapsing Neuromyelitis Optica

References

1. ↵
   Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Treat Options Neurol 2005;7:173–82

   CrossRefPubMed
2. ↵
   Bergamaschi R, Ghezzi A. Devic’s neuromyelitis optica: clinical features and prognostic factors. Neurol Sci 2004;25:S364–67
3. Ghezzi A, Bergamaschi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica. J Neurol 2004;251:47–52

   CrossRefPubMed
4. ↵
   Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003;60:848–53

   Abstract/FREE Full Text
5. ↵
   O’Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996;60:382–87

   Abstract/FREE Full Text
6. ↵
   Wingerchuk DM, Hogancamp WF, O’Brien PC, et al. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999;53:1107–14

   Abstract/FREE Full Text
7. Correale J, Fiol M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 2004;63:2363–70

   Abstract/FREE Full Text
8. Nakashima I, Fujihara K, Fujimori J, et al. Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica. Neurology 2004;62:144–46

   Abstract/FREE Full Text
9. ↵
   Mandler RN, Davis LE, Jeffery DR, et al. Devic’s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993;34:162–68

   CrossRefPubMedWeb of Science
10. Lefkowitz D, Angelo JN. Neuromyelitis optica with unusual vascular changes. Arch Neurol 1984;41:1103–05

    CrossRefPubMed
11. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 2002;125:1450–61

    Abstract/FREE Full Text
12. ↵
    Mandler RN, Dencoff JD, Midani F, et al. Matrix metalloproteinase and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic’s neuromyelitis optica. Brain 2001;24:493–98
13. ↵
    Fazekas F, Offenbacher H, Strasser-Fuchs S. MRI of neuromyelitis optica: evidence for a distinct entity. J Neurol Neurosurg Psychiatry 1994;59:1140–42
14. ↵
    de Seze J, Stojkovic T, Ferriby D, et al. Devic’s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 2002;197:57–61

    CrossRefPubMedWeb of Science
15. ↵
    Cercignani M, Inglese M, Pagani E, et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22:952–58

    Abstract/FREE Full Text
16. Rovaris M, Gallo A, Valsasina P, et al. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI. Neuroimage 2005;24:1139–46

    CrossRefPubMedWeb of Science
17. Rashid W, Hadjiprocopis A, Griffin CM, et al. Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction. Mult Scler 2004;10:9–15

    Abstract/FREE Full Text
18. ↵
    Bozzali M, Cercignani M, Sormani MP, et al. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol 2002;23:899–900

    FREE Full Text
19. ↵
    Filippi M, Rocca M, Moiola L, et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica. Neurology 1999;53:1705–10

    Abstract/FREE Full Text
20. ↵
    Rocca MA, Agosta F, Mezzapesa DM, et al. Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 2004;62:476–78

    Abstract/FREE Full Text
21. ↵
    Rocca MA, Agosta F, Mezzapesa DM, et al. A functional MRI study of movement-associated cortical changes in patients with Devic’s neuromyelitis optica. NeuroImage 2004;21:1061–68

    CrossRefPubMed
22. ↵
    Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988;38:180–85

    Abstract/FREE Full Text
23. ↵
    Basser PJ, Mattiello J, Le Bihan D. Estimation of the effective self-diffusion tensor from the NMR spin-echo. J Magn Reson B 1994;103:247–54

    CrossRefPubMedWeb of Science
24. ↵
    Basser PJ, Pierpaoli C. Microstructural features measured using diffusion tensor imaging. J Magn Reson B 1996;111:209–19

    CrossRefPubMedWeb of Science
25. ↵
    Zhu C, Jiang T. Multicontext fuzzy clustering for separation of brain tissues in magnetic resonance images. Neuroimage 2003;18:685–96

    CrossRefPubMed
26. ↵
    Iannucci G, Rovaris M, Giacomotti L, et al. Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging. AJNR Am J Neuroradiol 2001;22:1462–67

    Abstract/FREE Full Text
27. ↵
    Filippi M, Cercignani M, Inglese M, et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56:304–11

    Abstract/FREE Full Text
28. ↵
    Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81–91

    CrossRefPubMedWeb of Science
29. Evangelou N, Esiri MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391–95

    CrossRefPubMedWeb of Science
30. Kidd D, Barkhof F, McConnel R, et al. Cortical lesions in multiple sclerosis. Brain 1999;122:17–26

    Abstract/FREE Full Text
31. ↵
    Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389–400

    CrossRefPubMedWeb of Science
32. ↵
    van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747–54

    CrossRefPubMedWeb of Science
33. ↵
    Filippi M, Bozzali M, Comi G. Magnetization transfer and diffusion tensor MR imaging of basal ganglia from patients with multiple sclerosis. J Neurol Sci 2001;183:69–72

    CrossRefPubMedWeb of Science
34. ↵
    Reiss AL, Hennessey JG, Rubin M, et al. Reliability and validity of an algorithm for fuzzy tissue segmentation of MRI. J Comput Assist Tomogr 1998;22:471–79

    CrossRefPubMedWeb of Science